Reporting owner · CIK 0001971187

Taich Adam

Visual SEC Form 4 history across 1 companies, 2 transactions and 2 filings.

CFOChief Financial Officer10x Genomics, Inc.
Open-market mix
Filings2Form 4 records
Buying$00 purchases
Selling$1.5M2 sales
Net value−$1.5MBuys minus sells
Companies11 securities
Most recentAug 24, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51May 261Aug 26

Net value flow

Buys minus sells

May 26
−$369K
Aug 26
−$1.1M

Transaction texture

Ownership and ticket size

Average P/S size$725.4K
Median P/S size$725.4K
Direct2
Indirect0
Aug 24, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at 10x Genomics, Inc. on Aug 24, 2026 valued at $1,081,853.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at 10x Genomics, Inc. on Aug 24, 2026 valued at $1,081,853.

Review SEC filing

Associated companies

Visual map of known reporting history

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
TXGTaich Adam
CFO
sale17.1k-$108MS08/2608/24
TXGTaich Adam
CFO
sale15.0k-$36.9MS+160.1%05/2705/22

Taich Adam Insider Activity FAQ

SEC Form 4 context

Who is Taich Adam?

Taich Adam is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001971187.

Which companies has Taich Adam reported transactions for?

10x Genomics, Inc.

When was Taich Adam's latest insider buy?

No open-market insider purchase is available for this period.

When was Taich Adam's latest insider sale?

sale at 10x Genomics, Inc. on Aug 24, 2026 valued at $1,081,853.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.